Irish pharma firm seeks $65m for cancer drug

17th December, 2014
Irish pharma firm seeks $65m for cancer drug
John Fox, chief executive, Merrion Pharmaceuticals. PIcture: Feargal Ward

Merrion Pharmaceuticals, the publicly quoted Irish pharma company, is seeking to raise $65 million from investors to fund a new breast cancer drug.

The company, which is traded on the small cap market in Dublin, is hoping to raise the money as soon as possible to fund clinical drug trials for a product it believes will drive it into the future.

Merrion is eyeing up either a new equity partner or a partnership deal on the...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Content is king – just ask Netflix as rivals attempt to steal its crown

Tom Maguire: Tax changes we make now could help business for years